van der Velden, VHJ ; Preijers, F ; Johansson, U...
issn:1552-4949.  , 2021

Loosdrecht, A.A ; Kern, W ; Porwit, A...
Loosdrecht , A A , Kern , W , Porwit , A , Valent , P , Kordasti , S , Cremers , E , Alhan , C , Duetz , C , Dunlop , A , Hobo , W , Preijers , F , Wagner-Ballon , O , Chapuis , N , Fontenay , M , Bettelheim , P , Eidenschink-Brodersen , L , Font , P , Johansson , U , Loken , M R , Marvelde , J G , Matarraz , S , Ogata , K , Oelschlaegel , U , Orfao , A , Psarra , K , Subira , D , Wells , D A , Bene , M C , Della Porta , M G , Burbury , K , Bellos , F , van der Velden , V H J , Westers , T M , Saft , L & Ireland , R 2021 , ' Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS-Flow Cytometry Working Group ' , Cytometry Part B-clinical Cytometry . https://doi.org/10.1002/cyto.b.22044.  , 2021

Loosdrecht, AA ; Kern, W ; Porwit, A...
issn:1552-4949.  , 2021

Mareque, M ; Montesinos, P ; Font, P...
ClinicoEconomics and outcomes research.  , 2021

van der Velden, V.H.J ; Preijers, F ; Johansson, U...
van der Velden , V H J , Preijers , F , Johansson , U , Westers , T M , Dunlop , A , Porwit , A , Bene , M C , Valent , P , te Marvelde , J , Wagner-Ballon , O , Oelschlaegel , U , Saft , L , Kordasti , S , Ireland , R , Cremers , E , Alhan , C , Duetz , C , Hobo , W , Chapuis , N , Fontenay , M , Bettelheim , P , Eidenshink-Brodersen , L , Font , P , Loken , M R , Matarraz , S , Ogata , K , Orfao , A , Psarra , K , Subira , D , Wells , D A , Della Porta , M G , Burbury , K , Bellos , F , Weiss , E , Kern , W & van de Loosdrecht , A 2021 , ' Flow cytometric analysis of myelodysplasia: Pre-analytical and technical issues-Recommendations from the European LeukemiaNet ' , Cytometry Part B-clinical Cytometry . https://doi.org/10.1002/cyto.b.22046.  , 2021

Mareque M ; Montesinos P ; Font P...
https://www.dovepress.com/cost-effectiveness-analysis-of-gemtuzumab-ozogamicin-for-first-line-tr-peer-reviewed-fulltext-article-CEOR.  , 2021

Mareque M ; Montesinos P ; Font P...
https://www.dovepress.com/corrigendum-cost-effectiveness-analysis-of-gemtuzumab-ozogamicin-for-f-peer-reviewed-fulltext-article-CEOR.  , 2021

Jara-Palomares, L ; Alfonso, M ; Maestre, A...
http://zaguan.unizar.es/record/97312.  , 2019

Ranchal Sánchez, Antonio ; Font, P ; Pérula de Torres, LA
https://doi.org/10.4321/S0465-546X2015000200004.  , 2015

van de Loosdrecht, AA ; Alhan, C ; Bene, MC...
van de Loosdrecht , AA , Alhan , C , Bene , MC , Della Porta , MG , Drager , AM , Feuillard , J , Font , P , Germing , U , Haase , D , Homburg , CH , Ireland , R , Jansen , JH , Kern , W , Malcovati , L , te Marvelde , J , Mufti , GJ , Ogata , K , Orfao , A , Ossenkoppele , GJ , Porwit , A , Preijers , FW , Richards , SJ , Schuurhuis , GJ , Subira , D , Valent , P , van der Velden , V , Vyas , P , Westra , AH , de Witte , TM , Wells , DA , Loken , MR & Westers , TM 2009 , ' Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes ' , Haematologica , vol. 94 , no. 8 , pp. 1124-1134 . https://doi.org/10.3324/haematol.2009.005801.  , 2009

La Font de Fressinet, P P. Auteur du texte
Notice du catalogue : http://catalogue.bnf.fr/ark:/12148/cb307153611.  , 1785

Adams, CB ; Batista, P ; Benbow, W...
info:eu-repo/semantics/altIdentifier/wos/WOS:000816875100001.  , 2022

Acciari, V. A ; Ansoldi, S ; Becerra González, J...
info:eu-repo/semantics/altIdentifier/issn/0004-6361.  , 2020

Abeysekara, A. U ; Benbow, W ; Bird, R...
info:eu-repo/semantics/altIdentifier/wos/WOS:000448968100003.  , 2018

Abeysekara, A. U ; Benbow, W ; Bird, R...
info:eu-repo/grantAgreement/HRZZ/IP/IP-2016-06-9782.  , 2018